MedPath
NMPA Approval

Sugammadex Sodium Injection

国药准字H20249085

October 16, 2024

Drug Information

舒更葡糖钠注射液

注射剂

按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg

化学药品

October 16, 2024

Company Information

Applicant Company

福建省福州市闽侯县上街镇科技东路12、16、18号华建大厦5号楼706-1

Manufacturing Company

中山火炬开发区国家健康基地内健康路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

舒更葡糖钠注射液 - NMPA 批准文号 | MedPath